Original scientific paper
https://doi.org/10.46419/cvj.57.6.10
Microbiological Safety Assessment of Canine Adipose Derived Mesenchymal Stem Cell Preparations Reveal no Detectable Contamination
Marina Prišlin Šimac
; Laboratory for Rabies and General Virology, Department for Virology, Croatian Veterinary Institute, 10000 Zagreb, Croatia
Valentina Kunić
; Laboratory for Serological Diagnosis of Viral Diseases, Department for Virology, Croatian Veterinary Institute, 10000 Zagreb, Croatia
*
Dragan Brnić
; Laboratory for Serological Diagnosis of Viral Diseases, Department for Virology, Croatian Veterinary Institute, 10000 Zagreb, Croatia
Daria Jurković Žilić
; Laboratory for Parasitology, Department for Bacteriology and Parasitology, Croatian Veterinary Institute, 10000 Zagreb, Croatia
Relja Beck
; Laboratory for Parasitology, Department for Bacteriology and Parasitology, Croatian Veterinary Institute, 10000 Zagreb, Croatia
Sanja Duvnjak
; Laboratory for Bacterial Zoonoses and Molecular Diagnosis of Bacterial Diseases, Department for Bacteriology and Parasitology, Croatian Veterinary Institute, 10000 Zagreb, Croatia
Manuela Zadravec
; Laboratory for Feed Microbiology, Department for Veterinary Public Health, Croatian Veterinary Institute, 10000 Zagreb, Croatia
Vjekoslava Kostanić
; Laboratory for Serological Diagnosis of Viral Diseases, Department for Virology, Croatian Veterinary Institute, 10000 Zagreb, Croatia
* Corresponding author.
Abstract
The experimental application of canine adipose-derived mesenchymal stem/stromal cells (cAD-MSC) has demonstrated excellent therapeutic potential in the treatment of a number of previously untreatable or difficult-to-treat diseases. However, the production of cAD-MSC for clinical application necessitates in vitro isolation and cell expansion, introducing the risk of microbiological contamination. Studies indicate that stored MSCs may be contaminated with bacteria, fungi, or viruses, resulting in cell transformation, cell death, or persistent infection. This ultimately compromises therapeutic efficacy and potentially facilitates therapy-induced pathogen transmission. In accordance with the European Medicines Agency guidelines mandating sterility testing as an integral component of the manufacturing process, this study aimed to assess the sterility of the cAD-MSC bank at the Croatian Veterinary Institute. To test for the most clinically significant canine pathogens, nucleic acids were extracted from 32 cAD-MSC preparations and analyzed using standard molecular PCR methods. The pathogen screening panel included rabies virus (Lyssavirus), canine herpesvirus (Varicellovirus canidalpha1), parvovirus (Carnivore protoparvovirus 1), coronavirus (Alphacoronavirus 1), distemper virus (Morbillivirus canis), Rotavirus A, Leptospira spp, Brucella canis, Borrelia burgdorferi sensu lato, Anaplasma spp, Ehrlichia spp, Mycoplasma spp (hemotropic), and Neospora caninum. No tested gene fragments of the aforementioned pathogens were detected, indicating that the cAD-MSC preparations were free from the presence of clinically significant pathogens. Rigorous implementation of sterility control during the cell isolation and expansion process is essential to ensure safe cell-based therapy in canine patients.
Keywords
adipose-derived mesenchymal stem cells; regenerative veterinary medicine; cell therapy; dog; microbial contamination
Hrčak ID:
351610
URI
Publication date:
15.11.2026.
Visits: 0 *